Richard Epstein (Chicago and NYU) has this piece — arguing that Congress should maintain preemption in the context of PMA-approved medical devices and extend similar protection to prescription drugs — at Forbes.com.
Epstein On Preemption In Forbes
The definitive source for intelligent commentary on the law that matters for drug and device product liability cases